Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma

13 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma

Record	Firm	Date
Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma (NCT04848064)	John Reneau	2022-05-06
Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas (NCT03373305)	City of Hope Medical Center	2019-03-01
Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer (NCT03432741)	Mayo Clinic	2018-03-27
Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma (NCT03409432)	John Reneau	2018-03-16
Study of Pembrolizumab (MK-3475) in Combination With Romidepsin (NCT03278782)	M.D. Anderson Cancer Center	2017-11-14
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma (NCT03017820)	Mayo Clinic	2017-04-04
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction (NCT01638533)	National Cancer Institute (NCI)	2012-08-03
Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma (NCT01567709)	National Cancer Institute (NCI)	2012-04-16
Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers (NCT01254578)	National Cancer Institute (NCI)	2010-11-24
O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma (NCT00961220)	National Cancer Institute (NCI)	2010-02-01

Track Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.